Collectively, the mechanisms of SMC1A knockdown inhibiting CRC cell proliferation and cell cycle progression may occur, in part, via the blockade of Akt and MAP kinase activation and the subsequent suppression of CDK4 and PCNA. The gene discussed is SMC1A; the disease is colorectal carcinoma.